Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone : Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-α

• DEROSA Giuseppe

  Department of Internal Medicine and Therapeutics, University of Pavia

• CICERO Arrigo F. G.

  G. Descovich Atherosclerosis Study Center, D. Campanacci Clinical Medicine and Applied Biotechnology Department, University of Bologna

• D'ANGELO Angela

  Department of Internal Medicine and Therapeutics, University of Pavia

• RAGONESI Pietro D.

  Diabetes Care Unit, S. Carlo Hospital

• CICCARELLI Leonardina

  Department of Internal Medicine and Therapeutics, University of Pavia

• PICCINNI Mario N.

  Department of Internal Medicine and Therapeutics, University of Pavia

• PRICOLO Fabio

  Department of Internal Medicine and Therapeutics, University of Pavia

• SALVADEO Sibilla A. T.

  Department of Internal Medicine and Therapeutics, University of Pavia

• FERRARI Ilaria

  Department of Internal Medicine and Therapeutics, University of Pavia

• GRAVINA Alessia

  Department of Internal Medicine and Therapeutics, University of Pavia

• FOGARI Roberto

  Department of Internal Medicine and Therapeutics, University of Pavia

Journal

• Hypertens Res

  Hypertens Res 29 (11), 849-856, 2006-11-01

Keywords

• telmisartan
• irbesartan
• rosiglitazone
• type 2 diabetes
• metabolic syndrome

Details

• CRID: 1572261550264267904
• NII Article ID: 10018831685
• NII Book ID: AA10847079
• ISSN: 09169636
• Web Site: https://search.jamas.or.jp/link/ui/2007159948
• Text Lang: en
• Data Source:
  • CiNii Articles